Associated Papers
Targeting IL-1 controls refractory pityriasis rubra pilaris.
Schmauch E et al.
Science Advances, 2024
38959302 (PubMed )
Supplement: sciadv.ado2365_sm.pdf
Association of CARD14 Single-Nucleotide Polymorphisms with Psoriasis.
Suleman S et al.
International Journal of Molecular Sciences, 2022
CARD14-mutations in pityriasis rubra pilaris and therapeutic response to ustekinumab - a hypothesis.
Volc-Platzer B
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : Jddg, 2020
Regulation and dysregulation of CARD14 signalling and its physiological consequences in inflammatory skin disease.
Mellett M
Cellular Immunology, 2020
CARD14-associated papulosquamous eruption: A spectrum including features of psoriasis and pityriasis rubra pilaris.
Craiglow BG et al.
Journal of the American Academy of Dermatology, 2018
CARD14/CARMA2 Signaling and its Role in Inflammatory Skin Disorders.
Zotti T et al.
Frontiers in Immunology, 2018
Clinical and Genetic Heterogeneity of CARD14 Mutations in Psoriatic Skin Disease.
Israel L et al.
Frontiers in Immunology, 2018
Pityriasis Rubra Pilaris Type V as an Autoinflammatory Disease by CARD14 Mutations.
Takeichi T et al.
Jama Dermatology, 2017
Select a paper to view details